Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38

Details for Australian Patent Application No. 2006301446 (hide)

Owner MorphoSys AG

Inventors Jager, Ute; Tesar, Michael

Agent Watermark

Pub. Number AU-B-2006301446

PCT Pub. Number WO2007/042309

Priority 60/725,297 12.10.05 US

Filing date 12 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 7 June 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/042309 Priority application(s): WO2007/042309

20 August 2009 Amendment Made

  The nature of the amendment is: Add the co-inventor Jager, Ute

7 June 2012 Application Accepted

  Published as AU-B-2006301446

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301458-Kinase inhibitors

2006301435-Pyrrolopyrimidine derivatives as Syk inhibitors